Home › Stock analysis › NKTX
Nkarta (NKTX) Stock: Why It Moved Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
What changed since yesterday
- Trading at $1.80 as of 12:05 PM ET, +0.00% vs the prior close of $1.80.
- Volume 465.78K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NKTX is flat (+0.0%) to $1.80, 6 down days in a row. Trading at $1.80 (intraday, 12:05 PM ET), +0.00% vs the prior close of $1.80. Day range $1.77–$1.85, opened at $1.84.
Price (intraday)$1.80+0.00%
Day range1.77–1.85
Open1.84
Volume465.78K
52-week range1.70–3.72
Avg volume (20d)738.31K
NKTX daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — NKTX is flat (+0.0%) to $1.80, 6 down days in a row
- Trading at $1.80 (intraday, 12:05 PM ET), +0.00% vs the prior close of $1.80. Day range $1.77–$1.85, opened at $1.84.
- Volume was 465.78K shares, 0.7x its 50-day average of 628.81K.
- Price is -29.9% vs its 50-day average ($2.57) and -29.4% vs its 200-day average ($2.55).
- 52-week range $1.70–$3.72; the current price sits at 5% of that range, 51.6% below the 52-week high.
- That makes 6 straight losses.
Oct 16, 2026 — NKTX slides 6.7% to $1.80, a 6-month low on 2.9x normal volume
- Closed at $1.80, -6.74% vs the prior close of $1.93. Day range $1.78–$1.94, opened at $1.93.
- Volume was 1.75M shares, 2.9x its 50-day average of 607.70K — unusually heavy trading.
- Price is -30.3% vs its 50-day average ($2.58) and -29.4% vs its 200-day average ($2.55).
- 52-week range $1.70–$3.72; today's close sits at 5% of that range, 51.6% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — NKTX slides 4.9% to $1.93, a 6-month low on 2.5x normal volume
- Closed at $1.93, -4.93% vs the prior close of $2.03. Day range $1.91–$2.07, opened at $2.05.
- Volume was 1.48M shares, 2.5x its 50-day average of 594.30K — unusually heavy trading.
- Price is -25.5% vs its 50-day average ($2.59) and -24.3% vs its 200-day average ($2.55).
- 52-week range $1.70–$3.72; today's close sits at 11% of that range, 48.1% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — NKTX slides 3.3% to $2.03, a 6-month low, 3 down days in a row
- Closed at $2.03, -3.33% vs the prior close of $2.10. Day range $2.02–$2.11, opened at $2.08.
- Volume was 702.30K shares, 1.2x its 50-day average of 595.27K.
- Price is -21.8% vs its 50-day average ($2.60) and -20.3% vs its 200-day average ($2.55).
- 52-week range $1.70–$3.72; today's close sits at 16% of that range, 45.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — NKTX slides 3.2% to $2.10, a 1-month low
- Closed at $2.10, -3.23% vs the prior close of $2.17. Day range $2.05–$2.18, opened at $2.15.
- Volume was 790.60K shares, 1.3x its 50-day average of 591.65K.
- Price is -19.3% vs its 50-day average ($2.60) and -17.6% vs its 200-day average ($2.55).
- 52-week range $1.70–$3.72; today's close sits at 20% of that range, 43.5% below the 52-week high.
Oct 12, 2026 — NKTX slides 3.6% to $2.17, a 1-month low
- Closed at $2.17, -3.56% vs the prior close of $2.25. Day range $2.14–$2.28, opened at $2.25.
- Volume was 598.40K shares, 1.0x its 50-day average of 593.35K.
- Price is -16.6% vs its 50-day average ($2.60) and -14.8% vs its 200-day average ($2.55).
- 52-week range $1.70–$3.72; today's close sits at 23% of that range, 41.7% below the 52-week high.
Oct 9, 2026 — NKTX rises 1.4% to $2.25
- Closed at $2.25, +1.35% vs the prior close of $2.22. Day range $2.14–$2.31, opened at $2.23.
- Volume was 904.90K shares, 1.5x its 50-day average of 590.29K.
- Price is -13.5% vs its 50-day average ($2.60) and -11.6% vs its 200-day average ($2.54).
- 52-week range $1.70–$3.72; today's close sits at 27% of that range, 39.5% below the 52-week high.
Oct 8, 2026 — NKTX dips 2.2% to $2.22, a 1-month low, 4 down days in a row
- Closed at $2.22, -2.20% vs the prior close of $2.27. Day range $2.16–$2.26, opened at $2.25.
- Volume was 720.20K shares, 1.2x its 50-day average of 589.73K.
- Price is -14.6% vs its 50-day average ($2.60) and -12.7% vs its 200-day average ($2.54).
- 52-week range $1.70–$3.72; today's close sits at 26% of that range, 40.3% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — NKTX dips 1.7% to $2.27, a 1-month low, 3 down days in a row
- Closed at $2.27, -1.73% vs the prior close of $2.31. Day range $2.25–$2.34, opened at $2.26.
- Volume was 566.50K shares, 1.0x its 50-day average of 590.24K.
- Price is -12.6% vs its 50-day average ($2.60) and -10.6% vs its 200-day average ($2.54).
- 52-week range $1.70–$3.72; today's close sits at 28% of that range, 39.0% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — NKTX slides 8.7% to $2.31, a 1-month low
- Closed at $2.31, -8.70% vs the prior close of $2.53. Day range $2.30–$2.55, opened at $2.55.
- Volume was 754.60K shares, 1.3x its 50-day average of 591.29K.
- Price is -11.0% vs its 50-day average ($2.60) and -9.0% vs its 200-day average ($2.54).
- 52-week range $1.70–$3.72; today's close sits at 30% of that range, 37.9% below the 52-week high.
Oct 5, 2026 — NKTX dips 1.7% to $2.53, a 1-month low
- Closed at $2.53, -1.75% vs the prior close of $2.58. Day range $2.45–$2.57, opened at $2.57.
- Volume was 522.10K shares, 0.9x its 50-day average of 594.83K.
- Price is -2.5% vs its 50-day average ($2.59) and -0.2% vs its 200-day average ($2.53).
- 52-week range $1.70–$3.72; today's close sits at 41% of that range, 32.0% below the 52-week high.
Oct 2, 2026 — NKTX rises 0.6% to $2.58
- Closed at $2.58, +0.59% vs the prior close of $2.56. Day range $2.52–$2.62, opened at $2.60.
- Volume was 366.80K shares, 0.6x its 50-day average of 606.39K.
- Price is -0.6% vs its 50-day average ($2.59) and +1.7% vs its 200-day average ($2.53).
- 52-week range $1.70–$3.72; today's close sits at 43% of that range, 30.8% below the 52-week high.
NKTX bull case vs bear case (from the data)
Bull case
- No clear positive signal in the price trend, filings or insider data right now.
Bear case
- Price is -29.9% vs its 50-day average — short-term trend is down.
- Price is -29.4% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $104.08M.
- Insider selling outweighs buying: 12 sales vs 0 open-market buys among the 12 most recent reported insider trades (Form 4, last 12 months).
- High volatility: average daily move of 3.0% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
NKTX latest news & SEC filings
Every SEC filing by or about NKTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$40.37M (prior year -$22.98M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.54 (prior year -$0.31) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hastings Paul J sold 1,776 shares at $2.71 (≈$4.81K) on Jun 18, 2026
- Hastings Paul J sold 1,776 shares at $2.71 (≈$4.81K) on Jun 18, 2026
- Hastings Paul J sold 1,776 shares at $2.71 (≈$4.81K) on Jun 18, 2026
- Hastings Paul J sold 1,776 shares at $2.71 (≈$4.81K) on Jun 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade NKTX
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 25, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.04% (largest 8.7%). That is a volatile stock.
- Liquidity: about 738.31K shares (≈$1.33M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.80 vs a range of $1.70–$3.72 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 12 sales; latest: Paul J Hastings sold 1,776 shares on Jun 18, 2026.
- Latest filings: 10-Q Aug 10, 2026; 8-K Aug 10, 2026; 8-K Jun 11, 2026.
- Share count: 71.62M shares outstanding (Aug 5, 2026), +0.8% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NKTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 1.84 | 1.85 | 1.77 | 1.80 | 465.78K |
| Oct 16, 2026 | 1.93 | 1.94 | 1.78 | 1.80 | 1.75M |
| Oct 15, 2026 | 2.05 | 2.07 | 1.91 | 1.93 | 1.48M |
| Oct 14, 2026 | 2.08 | 2.11 | 2.02 | 2.03 | 702.30K |
| Oct 13, 2026 | 2.15 | 2.18 | 2.05 | 2.10 | 790.60K |
| Oct 12, 2026 | 2.25 | 2.28 | 2.14 | 2.17 | 598.40K |
| Oct 9, 2026 | 2.23 | 2.31 | 2.14 | 2.25 | 904.90K |
| Oct 8, 2026 | 2.25 | 2.26 | 2.16 | 2.22 | 720.20K |
| Oct 7, 2026 | 2.26 | 2.34 | 2.25 | 2.27 | 566.50K |
| Oct 6, 2026 | 2.55 | 2.55 | 2.30 | 2.31 | 754.60K |
| Oct 5, 2026 | 2.57 | 2.57 | 2.45 | 2.53 | 522.10K |
| Oct 2, 2026 | 2.60 | 2.62 | 2.52 | 2.58 | 366.80K |
| Oct 1, 2026 | 2.59 | 2.67 | 2.55 | 2.56 | 402.30K |
| Sep 30, 2026 | 2.65 | 2.69 | 2.55 | 2.62 | 283.20K |
| Sep 29, 2026 | 2.68 | 2.68 | 2.53 | 2.62 | 524.60K |
| Sep 28, 2026 | 2.75 | 2.79 | 2.67 | 2.67 | 810.70K |
| Sep 25, 2026 | 2.86 | 2.86 | 2.72 | 2.75 | 681.10K |
| Sep 24, 2026 | 2.72 | 2.89 | 2.59 | 2.85 | 933.80K |
| Sep 23, 2026 | 2.91 | 2.99 | 2.62 | 2.76 | 1.09M |
| Sep 22, 2026 | 2.92 | 2.98 | 2.87 | 2.95 | 415.60K |
About Nkarta
Nkarta (NKTX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1787400.
NKTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ali Behbahani | Director | Jun 11, 2026 |
| Michael Dybbs | Director | Jun 11, 2026 |
| Simeon George | Director | Jun 11, 2026 |
| Paul J Hastings | Chief Executive Officer | Jun 22, 2026 |
| Peter Kolchinsky | Director | Jun 11, 2026 |
| Leone D Patterson | Director | Jun 11, 2026 |
| Capital Management, L.P. Ra | Director | Jun 11, 2026 |
| Capital Healthcare Fund Lp Ra | Director | Jun 11, 2026 |
| Capital Nexus Fund, L.P. Ra | Director | Jun 11, 2026 |
| Zachary Scheiner | Director | Jun 11, 2026 |
| Rajeev M. Shah | Director | Jun 11, 2026 |
| Angela Thedinga | Director | Jun 11, 2026 |
| George Vratsanos | Director | Jun 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul J Hastings | Chief Executive Officer | Jun 22, 2026 |
| Nadir Mahmood | President | Jan 20, 2026 |
| Shawn Marshall Rose | See Remarks | Jan 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | Paul J Hastings | Sale | 1,776 | $2.71 |
| Jun 18, 2026 | Paul J Hastings | Sale | 1,776 | $2.71 |
| Jun 18, 2026 | Paul J Hastings | Sale | 1,776 | $2.71 |
| Jun 18, 2026 | Paul J Hastings | Sale | 1,776 | $2.71 |
| Jan 15, 2026 | Paul J Hastings | Sale | 26,046 | $2.07 |
| Jan 15, 2026 | Paul J Hastings | Sale | 26,046 | $2.07 |
| Jan 15, 2026 | Paul J Hastings | Sale | 26,046 | $2.07 |
| Jan 15, 2026 | Paul J Hastings | Sale | 26,046 | $2.07 |
| Jan 15, 2026 | Nadir Mahmood | Sale | 5,649 | $2.07 |
| Jan 15, 2026 | Nadir Mahmood | Sale | 5,649 | $2.07 |
| Jan 15, 2026 | Nadir Mahmood | Sale | 5,649 | $2.07 |
| Jan 15, 2026 | Nadir Mahmood | Sale | 5,649 | $2.07 |
NKTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $0 | $-104.08M | -1.41 | $-88.70M |
| Dec 31, 2024 | $0 | $-108.79M | -1.60 | $-99.70M |
| Dec 31, 2023 | — | $-117.50M | -2.40 | $-86.16M |
| Dec 31, 2022 | — | $-113.84M | -2.61 | $-57.00M |
| Dec 31, 2021 | $0 | $-86.08M | -2.62 | $-67.93M |
Latest balance sheet: total assets $337.64M, total liabilities $89.91M, cash $24.96M (as of Jun 30, 2026).
NKTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $2.46 |
| May 12, 2026 | 8-K Item 2.02 (results) | $3.28 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $2.13 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $1.96 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $1.96 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.87 |
| Mar 26, 2025 | 8-K Item 2.02 (results) | $1.37 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $3.27 |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 21, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Oct 17, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on NKTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.